Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply.

Saved in:
Bibliographic Details
Title: Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Disease. Authors' Reply.
Authors: García JLR; Gastroenterology, La Paz University Hospital, Madrid, Spain.; IdiPAZ Study Group on Immune-Mediated Gastrointestinal Diseases, La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., Suárez-Ferrer C; Gastroenterology, La Paz University Hospital, Madrid, Spain.; IdiPAZ Study Group on Immune-Mediated Gastrointestinal Diseases, La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., Zabana Y; Gastroenterology, Hospital Universitari Mútua Terrassa, Terrassa, Catalonia, Spain.; Centro de investigación biomédica en Red de Enfermedades Hepáticas y Digestivas (CiberEHD), Madrid, Spain.
Corporate Authors: Young Group of GETECCU (Spanish Working Group on Crohn's Disease and Ulcerative Colitis)
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Jun; Vol. 63 (12), pp. 1705-1706. Date of Electronic Publication: 2026 May 12.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1365-2036
DOI:10.1111/apt.70715